ACR Convergence 2025| Video: Rheum for Everyone, Episode 26—Ableism

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Lupus Nephritis
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • Technology
      • Information Technology
      • Apps
    • QA/QI
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
      • Education & Training
    • Certification
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

The Pros & Cons of AI

Thomas R. Collins  |  November 5, 2025

CHICAGO—Artificial intelligence (AI) is growing more and more sophisticated for use in rheumatology and the medical field, offering clinicians a staggering number of options for how to potentially deploy it. From aiding diagnosis to prior authorizations to clinical trial recruitment, AI can help common, simple tasks be completed quickly, ease the cognitive demand of more challenging work and perform tasks that would be impossible if not for AI, said Jeff Curtis, MD, endowed professor of medicine at the University of Alabama at Birmingham, in a session at ACR Convergence 2025.

In a counterargument during the session, Jinoos Yazdany, MD, MPH, endowed professor of medicine at the University of California, San Francisco, warned that AI, although helpful, is rife with issues of increasing bias in the practice of medicine, meager regulatory oversight and a lack of transparency.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

How AI Is Being Used in Medicine

Jeffrey Curtis, MD, MS, MPH

Jeffrey Curtis, MD, MS, MPH

OpenEvidence, an AI-enabled medical search platform, is one of the most used AI tools, and typically performs quite well, Dr. Curtis said.

“You can just ask [about] a patient’s scenario, and it gives you both clinical reasoning and literature search,” he said. “It rarely hallucinates what that literature is,” unlike other large language models. However, it still does occasionally hallucinate both the prompt and the response, he added.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

“AI is not necessarily artificial intelligence as much as augmented intelligence—it reminds you of things that you probably already knew and would have eventually thought of but can be very helpful as your thought partner,” Dr. Curtis said.

AI tools can help process prior authorizations. But this kind of tool is best integrated with the electronic medical records so that information, such as ICD10 codes, indications and treatment history, can be extracted.

He warned that “of course insurance companies are using it AI against us, and they have much deeper pockets.” He noted a class-action suit against Cigna for its use of AI for quick denials, but he held out hope for a “more rational AI system that has fair balance to reflect all stakeholder views.” Thus, suggesting that the fear of big legal settlements may motivate insurance companies to come to the table.

AI can also be used to help put together clinical trials, evaluating eligibility criteria, defining cohorts, designing studies and recruiting patients.

Physicians have also found AI helpful for drafting reponses to portal messages from patients, Dr. Curtis said. One randomized trial actually found that an AI tool did not save time on this task due to the time needed to review the AI responses. However, physicians still tended to like the tool, in part because—at the end of a long day—it can be hard to be empathetic when responding to patient queries, and AI can help draft suitable responses, Dr. Curtis said.1

Page: 1 2 3 | Single Page
Share: 

Filed under:ACR ConvergenceMeeting ReportsTechnology Tagged with:ACR Convergence 2025AIartificial intelligenceclinical decision making

Related Articles

    An Evidence-Based Drug Update & Guidance for Rheumatologists

    August 14, 2022

    ORLANDO—Despite the COVID-19 pandemic, the past two years have been exciting for rheumatology providers and patients. We’ve seen the U.S. Food & Drug Administration (FDA) approve new therapies and expand indications for established drugs. At the 2022 ACR Education Exchange, Jeffrey Curtis, MD, MS, MPH, Marguerite Jones Harbert-Gene Ball Endowed professor of medicine, Division of…

    Editor's Pick

    Incorporating Patient-Reported Outcomes into the Clinic

    May 5, 2025

    ‘Measuring patient-reported outcomes (PROs) is an important component of high-quality, patient-centered care, but integration of PROs into clinic can be challenging,’ says Physician Editor Bharat Kumar, MD, MME, FACP, FAAAAI, RhMSUS. ‘Luckily, tools exist to help us realize this vital aspect of patient care.’ The ACR’s quality measures for care include gauging disease activity and…

    Andrey_Popov / shutterstock.com

    Rheumatology & Digital Wearables: What’s on the Horizon?

    May 15, 2020

    SNOWMASS VILLAGE, COLO.—A major workforce shortage, a population of patients taking immunosuppressants where safety concerns and the patient experience are critical, and an increasing focus on remote patient monitoring and telehealth are driving a discussion regarding the role digital wearables play in rheumatologic care. “We need to be more thoughtful and efficient in taking care…

    LeoWolfert / shutterstock.com

    Precision Medicine Today: Predicting Treatment Response in Patient Subgroups

    May 15, 2020

    SNOWMASS VILLAGE, COLO.—Choosing the right treatment at the right time is the brass ring all rheumatologists hope for. Precision medicine provides the ability to leverage clinical, biomarker and omics data to predict and personalize future treatment for rheumatoid arthritis (RA). “New data and new methods to analyze the data are helping us better predict patterns…

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences